View Author
Peters, H.
( H. Peters)
patient cancer tumor breast mutation level response tamoxifen breast cancer factor tp 53 status tamoxifen treatment treatment growth factor breast tumors vegf status analysis study growth estrogen vegf levels month protein breast cancer patients value base model expression multivariate wild-type tp 53 tp 53 gene tp 53 status model therapy er-positive vegf production survival disease association tissue multivariate analysis foeken response rate vegf level relapse wild-type receptor tamoxifen therapy effect vegf expression levels regression progression-free survival tumor characteristics er-positive tumors odds ratio tp 53 genotype table viscera adjuvant chemotherapy multivariate models 0.22 result spearman rank correlation klijn estrogen response elements first-line tamoxifen treatment reading frame ratio variable adjuvant follow-up netherland 2001. inhibitor relationship range subset production univariate cytosolic
1 Most Recent Publications
|
Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer
(Article)
Berns, P.M.J.J. Portengen, H. Vossen, R. Peters, H. Geurts-Moespot, A. Staveren, I.L. van Foekens, J.A. Meijer van Gelder, M.E. Sweep, F.C. Bakker, B. Klijn, J.G.M. Look, M.P. Grebenchtchikov, N. |
2003-01-01
|